North Atlantic Innovative Relations of Swiss Pharmaceuticals and the Proximities with Regional Biotech Arenas
Bibliographic Data
| ID | 4903683 |
|---|---|
| Authors | Christian Zeller (Universidad Iberoamericana, corresponding author) |
| Year | 2004 |
| Volume | 80 |
| Issue | 1 |
| Pages | 83-111 |
| Publication date | 2004-01-01 |
| Peer Reviewed | Yes |
| Open Access | Yes |
| Type | ARTICLE |
| Venue | Economic Geography (JOURNAL) |
| Journal identifiers | ISSN: 0013-0095 • E-ISSN: 1944-8287 |
| Publisher | Wiley (PUBLISHER • GB) |
| DOI | 10.1111/j.1944-8287.2004.tb00230.x |
| OpenAlex | W2152023665 |
| Language | EN |
| Citations received | 36 |
| References cited | 55 |
Under the pressure of increased global competition and processes of concentration, the pharmaceutical giants are reorganizing their innovative capacities. Technology and research and development (R&D) play a key role in the competitive strategies of multinational pharmaceutical companies. This article analyzes the interrelation of the far-reaching but spatially selective international expansion of R&D and technology of a major Swiss pharmaceutical company and its anchoring in regional arenas of innovation. It combines this international technological expansion with a perspective on integrating spatial and social proximities. Multinational corporations (MNCs) tend to locate their R&D activities in regions that are characterized by a richness of knowledge. The structure of inter- and intrafirm networks is shaped by the geography of talent. The Swiss pharmaceutical giants made substantial efforts to anchor themselves in regional arenas of innovation, such as the San Francisco Bay Area, Boston, and San Diego. A case study of a pharmaceutical giant's embedding in the biotech arena of San Diego reveals how oligopolistic rivals fight over privileged access to spatially concentrated bases of technology. MNCs attempt to create, complement, and substitute spatial proximity with other types of social proximities, internal as well as external to their own organizations. These efforts contribute to the generation of specific global-local interfaces in the processes of global scanning, transferring, and generating new pharmaceutical compounds and technologies
Biology · Business · Competition (biology) · Economic geography · Economics · Industrial organization · Multinational corporation · Pharmaceutical industry · Regional science · Sociology · Biotechnology · Biotechnology and Related Fields · Ecology · Innovation and Knowledge Management · Pharmaceutical Economics and Policy
Border region economies
Industrial Cluster Dynamics
Proximity and inter‐organizational collaboration
Regionally asymmetric knowledge capabilities and open innovation
Cluster life cycles--dimensions and rationales of cluster evolution
Foreign direct investment in Europe by multinational pharmaceutical companies from India
The geography of learning and knowledge acquisition among Asian latecomers
The creation of knowledge
Enhancing SME innovation across European regions
R&D activities and innovation performance of MNE subsidiaries
Extensive Dynamics of Global Collaboration Network for Scientific Breakthroughs
US-Asia Interdependencies
Knowledge Collaboration and Proximity
From the gene to the globe
Enterprise hubs as a mechanism for local economic development in rural areas
The geographics of patients transfers
Institutions, Location, and Networks of Multinational Enterprises in China
Evaluating the Travel Distances of Events Visitors and Regular Visitors Using Mobile Positioning Data
Towards a Geography of Knowledge Creation
The transboundary automotive region of Saar-Lor-Lux
Necessary restructuring or globalization failure? Shifts in regional supplier relations after the merger of the former German Hoechst and French Rhône-Poulenc groups
Global Knowledge and Creativity
Too much of a good thing? Network brokerage within and between regions and innovation performance
Interrelating Dynamic Proximities by Bridging, Reducing and Producing Distances
On the Role and Interrelationship of Spatial, Social and Cognitive Proximity
Substitution or Overlap? The Relations between Geographical and Non-spatial Proximity Dimensions in Collaborative Innovation Projects
The Pharma-biotech Complex and Interconnected Regional Innovation Arenas
Spatial Concentration in the I rish Pharmaceutical Industry
Developing survey metrics for analysing cross-border proximity
The knowledge–space dynamic in the UK bioeconomy
Alliance‐Driven Governance
Rethinking Economic Geographies of Knowledge
Knowledge, Space and Biotechnology
Juggling with Proximity and Distance
Innovation, Globalization, and Catch-Up of Latecomers
Explaining Spatial Patterns of Innovation
The regional world
The Geography of Innovation
Localised learning and industrial competitiveness
Towards an explanation of regional specialization and industry agglomeration
Regional systems of innovation?
Technical change and economic theory
Multinational enterprises and the global economy
An evolutionary theory of economic change
Globalisierungsstrategien — Der Weg von Novartis
Clustering Biotech
The Role of Small Firms in U.S. Biotechnology Clusters
Project Teams as Means of Restructuring Research and Development in the Pharmaceutical Industry
On the Analytical Dimension of Proximity Dynamics
The Globalisation of Production and Technology
The Economic Geography of Talent
A Bitter Pill
Sticky Places in Slippery Space
Neo-Marshallian Nodes in Global Networks
Ecologies of Creativity
Industrial Change and Regional Development
Rescaling Power Relations between Trade Unions and Corporate Management in a Globalising Pharmaceutical Industry
The Rescaling of Labour Regulation in Germany
Being There
Firms in Territories
| Unique citing works | 36 |
|---|---|
| Citations per year | 1,71 |
| Citation span | 2005 - 2026 (22) |
| Citation velocity | current |
| Highly cited | No |
| Citation types | Neutral: 35 |